Literature DB >> 17900561

Performance- and task-dependent effects of the dopamine D1/D5 receptor agonist SKF 38393 on learning and memory in the rat.

Francesco Amico1, Laura Spowart-Manning, Roger Anwyl, Michael J Rowan.   

Abstract

Dopamine D(1)/D(5) receptor agonists may enhance cognition by mimicking dopamine's neurophysiological actions on the processes underlying learning and memory. The present study examined the task- and performance- dependence of the cognitive effects of a partial agonist at dopamine D(1)/D(5) receptors, SKF 38393 [(+/-)-1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrobromide], in rats. Spatial working memory was assessed in a T-maze, spatial reference memory in a water maze and habituation learning in a novel environment, a hole board. The muscarinic acetylcholine receptor antagonist scopolamine (1.5 mg/kg, i.p.) was used to cause an impairment of performance of these learning tasks. Administration of SKF 38393 (6 mg/kg, i.p.) alone had no significant effect on spontaneous alternation in the T-maze, latency to escape to a hidden platform in the water maze or the habituation of spontaneous behaviour in the hole board. In contrast, in scopolamine-treated rats, whereas SKF 38393 prevented the scopolamine-induced deficit in the T-maze, it exacerbated the impairment in the water maze and did not significantly alter the disruption of habituation. These results suggest that dopamine D(1)/D(5) receptor activation has performance- and task-dependent effects on cognitive function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900561     DOI: 10.1016/j.ejphar.2007.08.039

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Working memory span capacity improved by a D2 but not D1 receptor family agonist.

Authors:  Isadore S Tarantino; Richard F Sharp; Mark A Geyer; Jessica M Meves; Jared W Young
Journal:  Behav Brain Res       Date:  2011-01-11       Impact factor: 3.332

2.  The Acute Pharmacological Manipulation of Dopamine Receptors Modulates Judgment Bias in Japanese Quail.

Authors:  Katarína Pichová; Ľubica Kubíková; Ľubor Košťál
Journal:  Front Physiol       Date:  2022-05-11       Impact factor: 4.755

3.  The effects of psychotomimetic and putative cognitive-enhancing drugs on the performance of a n-back working memory task in rats.

Authors:  Tracey Ko; John Evenden
Journal:  Psychopharmacology (Berl)       Date:  2008-09-30       Impact factor: 4.530

4.  Distinct roles of methamphetamine in modulating spatial memory consolidation, retrieval, reconsolidation and the accompanying changes of ERK and CREB activation in hippocampus and prefrontal cortex.

Authors:  Guofen Cao; Jie Zhu; Qing Zhong; Chaofeng Shi; Yonghui Dang; Wei Han; Xinshe Liu; Ming Xu; Teng Chen
Journal:  Neuropharmacology       Date:  2012-11-14       Impact factor: 5.250

5.  Developmental changes in human dopamine neurotransmission: cortical receptors and terminators.

Authors:  Debora A Rothmond; Cynthia S Weickert; Maree J Webster
Journal:  BMC Neurosci       Date:  2012-02-15       Impact factor: 3.288

6.  Rethinking schizophrenia in the context of normal neurodevelopment.

Authors:  Vibeke S Catts; Samantha J Fung; Leonora E Long; Dipesh Joshi; Ans Vercammen; Katherine M Allen; Stu G Fillman; Debora A Rothmond; Duncan Sinclair; Yash Tiwari; Shan-Yuan Tsai; Thomas W Weickert; Cynthia Shannon Weickert
Journal:  Front Cell Neurosci       Date:  2013-05-15       Impact factor: 5.505

7.  The effect of modafinil on the rat dopamine transporter and dopamine receptors D1-D3 paralleling cognitive enhancement in the radial arm maze.

Authors:  Yasemin Karabacak; Sunetra Sase; Yogesh D Aher; Ajinkya Sase; Sivaprakasam R Saroja; Ana Cicvaric; Harald Höger; Michael Berger; Vasiliy Bakulev; Harald H Sitte; Johann Leban; Francisco J Monje; Gert Lubec
Journal:  Front Behav Neurosci       Date:  2015-08-19       Impact factor: 3.558

8.  Effects of Fructus Akebiae on learning and memory impairment in a scopolamine-induced animal model of dementia.

Authors:  Jinghua Wang; Xuan Wang; Baosheng Lv; Weixiu Yuan; Zeguo Feng; Weidong Mi; Hong Zhang
Journal:  Exp Ther Med       Date:  2014-06-11       Impact factor: 2.447

9.  Targeting the dopamine D1 receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performance.

Authors:  Anton Pekcec; Niklas Schülert; Birgit Stierstorfer; Serena Deiana; Cornelia Dorner-Ciossek; Holger Rosenbrock
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

10.  The Signaling and Pharmacology of the Dopamine D1 Receptor.

Authors:  Jace Jones-Tabah; Hanan Mohammad; Emma G Paulus; Paul B S Clarke; Terence E Hébert
Journal:  Front Cell Neurosci       Date:  2022-01-17       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.